MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

AngioDynamics Inc

Abrir

SetorSaúde

9.49 -1.25

Visão Geral

Variação de preço das ações

24h

Atual

Mín

9.13

Máximo

9.68

Indicadores-chave

By Trading Economics

Rendimento

6.3M

-4.4M

Vendas

-841K

72M

EPS

-0.08

Margem de lucro

-6.12

Funcionários

748

EBITDA

-2.1M

-329K

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+65.78% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-8.8M

376M

Abertura anterior

10.74

Fecho anterior

9.49

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

AngioDynamics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

9 de dez. de 2024, 15:23 UTC

Grandes Movimentos do Mercado

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

9 de dez. de 2024, 15:20 UTC

Grandes Movimentos do Mercado

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

Comparação entre Pares

Variação de preço

AngioDynamics Inc Previsão

Preço-alvo

By TipRanks

65.78% parte superior

Previsão para 12 meses

Média 15.5 USD  65.78%

Máximo 16 USD

Mínimo 15 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para AngioDynamics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

2

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

9.4553 / 9.76Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Weak Bullish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.